AGMA Score of Sotiropoulos et al for a Patient Undergoing Liver Transplant for Hepatocellular Carcinoma

Description

Sotiropoulos et al reported the AGMA score for evaluating a patient with hepatocellular carcinoma who undergoes a liver transplant. This can help to identify a patient who may have a worse outcome after the transplant. The autors are from University Hospital Essen.

AGMA is an acronym for age, grade, MELD and AFP.

Patient selection: hepatocellular carcinoma undergoing liver transplant

Parameters:

(1) age

(2) histologic grade

(3) MELD score

(4) serum AFP in ng/mL

Parameter	Finding	Points
age	<= 60 years	1
	> 60 years	0
histologic grade	well (G1) or modeate (G2)	1
	poor (G3)	0
MELD score	<= 22	1
	> 22	0
serum AFP	<= 400 ng/mL	1
	> 400 ng/mL	0

total score =

= SUM(points for all of the parameters)

Interpretation:

• minimum score: 0

• maximum score: 4

• A low score is associated with a worse prognosis.

Total Score	5-Year Overall Survival
4	76%
3	47%
1 or 2	20%
0	NA

To read more or access our algorithms and calculators, please log in or register.